Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands
✍ Scribed by Anders Nordkvist; Joachim Mark; Hans Gustafsson; Gisle Bang; Dr. GÖRan Stenman
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 622 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
The chromosomal findings in 10 adenoid cystic carcinomas (ACC) of the salivary glands are described. Clonal numerical deviations as the sole anomaly were detected in four cases and structurally rearranged stemlines and sidelines in four cases. An apparently identical t(6;9)(q23;p2 I) was found in two tumors; in one case the translocation was part of the abnormal stemline and in the other case it was the sole anomaly in a single variant cell. A similar or identical t(6;9)(q21-24;p 13-23) has recently been reported in three of I5 previously published cases of ACC. The three remaining tumors with abnormal stemlines all had rearrangements of chromosome 9, including t( I ;9)(q21 ;p2 I -22), der(9)i( )(q I O)inv(9)(q I2q I 3). and der(X)t(XS)(pZI ;p22-23), respectively. The latter case also had a t( 17; I8)(p I Z;q I I .2) that was common to both abnormal clones present in this tumor.
In addition to other abnormalities, the clone with der(X)t(X9) also showed a del(6)(q I3q2I). In two cases fluorescence in situ hybridization (FISH) was used for further characterization of the marker chromosomes. A survey of the present findings together with previous results from I 5 ACC clearly demonstrates *at rearrangements of 6q2 1-24 (deletions or translocations in I I cases), 9p 13-23 (translocations in seven cases), and I7pl2-I 3 (translocations in three cases) are recurrent, and often primary, in ACC, and that the t(6;9)(q21-24;~13-23), found in five tumors, is a non-random, primary aberration. Genes Chmnosorn Cancer /0:1/5-/2/ (1994).
📜 SIMILAR VOLUMES
## Abstract ## Background. Paclitaxel is not considered to be an active drug in adenoid cystic carcinoma (ACC) of the salivary glands. We report 2 consecutive cases of patients with ACC who responded to paclitaxel. ## Methods. The patients were: (1) a 58‐year‐old man with recurrent ACC who devel
## Background: Epidermal growth factor (egf) and its receptor (egfr) are involved in the development of salivary gland tumors. recently, treatment modalities for egfr inhibition have shown an enhanced clinical response in carcinomas of different locations. adenoid cystic carcinoma (acc) of salivary
The objective of this study was to clarify extracellular materials (ECMs) in adenoid cystic carcinoma (AdCC) and compare these to those found in other salivary gland tumors with myoepithelial differentiation. The ECM was examined with Papanicolaou, May-Grünwald-Giemsa (MGG), and alcian blue stain at
Background. Adenoid cystic carcinoma (ACC) of the salivary gland shows a variable clinical course. It would be helpful to discover reliable biologic markers in the management of patients with ACC. Methods. We examined proliferating cell nuclear antigen (PCNA) and c-erbB-2 oncoprotein expression on